Manchester Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58K Buy
29
+3
+12% +$146 ﹤0.01% 1089
2026
Q1
$1.12K Hold
26
﹤0.01% 1111
2025
Q4
$1.14K Sell
26
-274
-91% -$11.3K ﹤0.01% 1114
2025
Q3
$12.4K Hold
300
﹤0.01% 835
2025
Q2
$13.2K Hold
300
﹤0.01% 790
2025
Q1
$11.1K Buy
+300
New +$10.7K ﹤0.01% 797

Other funds holding EXEL

Manchester Capital Management's EXEL Position: Q2 2026 in Review

Manchester Capital Management increased its Exelixis (EXEL) stake by 12% in Q2 2026, buying an estimated $146 and bringing the position to 29 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1089.

Manchester Capital Management first reported a position in EXEL in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.2K in Q2 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Manchester Capital Management held 29 shares of Exelixis worth $1.58K as of Q2 2026.
  • Manchester Capital Management bought 3 Exelixis shares in Q2 2026, an estimated $146.
  • Exelixis made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #1089 holding.
  • Manchester Capital Management first reported a position in Exelixis in Q1 2025 and has held it in 6 quarters since.
  • Manchester Capital Management's Exelixis position peaked at $13.2K in Q2 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.